Yingying Ding1, Zhonghui Ma1, Jiayu He1, Xiaoyi Xu1, Shijie Qiao1, Lulu Xu1, Ruizi Shi1, Xiaohui Xu1, Bowen Zhu1, Jing Li1, Frank Y Wong2,3, Na He4,5. 1. Department of Epidemiology, School of Public Health, and The Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai, China. 2. Center for Indigenous Nursing Research for Health Equity, Florida State University, Tallahassee, FL, USA. 3. Department of Psychology, University of Hawai`i at Mānoa, Honolulu, HI, USA. 4. Department of Epidemiology, School of Public Health, and The Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai, China. nhe@fudan.edu.cn. 5. Key Laboratory of Health Technology Assessment of Ministry of Health, Fudan University, P. O. Box 289, 138 Yi Xue Yuan Road, Shanghai, 200032, China. nhe@fudan.edu.cn.
Abstract
PURPOSE OF REVIEW: This review is intended to provide an overview of the evolution of HIV epidemiology over the past decade in China. RECENT FINDINGS: We provided a succinct overall view of the epidemic, followed by surveillance data, profiles of key populations, HIV molecular epidemiology, and drug resistance, as well as survival in the age of antiretroviral therapy usage. For each topical issue, we first reviewed the latest empirical evidence, followed by a brief summary assessment. We briefly addressed the challenges and opportunities of the next generation of HIV control and prevention efforts in China. Notably, macro-social factors need to be integrated into the next generation of clinical and/or behavioral HIV research to inform disease progression and management, as well as control and prevention.
PURPOSE OF REVIEW: This review is intended to provide an overview of the evolution of HIV epidemiology over the past decade in China. RECENT FINDINGS: We provided a succinct overall view of the epidemic, followed by surveillance data, profiles of key populations, HIV molecular epidemiology, and drug resistance, as well as survival in the age of antiretroviral therapy usage. For each topical issue, we first reviewed the latest empirical evidence, followed by a brief summary assessment. We briefly addressed the challenges and opportunities of the next generation of HIV control and prevention efforts in China. Notably, macro-social factors need to be integrated into the next generation of clinical and/or behavioral HIV research to inform disease progression and management, as well as control and prevention.
Authors: Joseph D Tucker; Rochelle P Walensky; Li-Gang Yang; Bin Yang; David R Bangsberg; Xiang-Sheng Chen; Myron S Cohen Journal: AIDS Care Date: 2012-04-18
Authors: Joseph T F Lau; Ming Wang; Hong Nei Wong; Hi Yi Tsui; Manhong Jia; Feng Cheng; Yun Zhang; Xiaoyou Su; Ning Wang Journal: Sex Transm Dis Date: 2008-04 Impact factor: 2.830
Authors: Fujie Zhang; Zhihui Dou; Ye Ma; Yan Zhao; Zhongfu Liu; Marc Bulterys; Ray Y Chen Journal: Ann Intern Med Date: 2009-08-18 Impact factor: 25.391
Authors: Peipei Xiao; Jianjun Li; Gengfeng Fu; Ying Zhou; Xiping Huan; Haitao Yang Journal: Int J Environ Res Public Health Date: 2017-07-24 Impact factor: 3.390
Authors: Tingting Yue; Pan Zhang; Yuantao Hao; Jianmei He; Jun Zheng; Erik De Clercq; Guangdi Li; Yaxiong Huang; Fang Zheng Journal: Front Public Health Date: 2022-06-09
Authors: Fangfang Chen; Houlin Tang; Juan Han; Dongmin Li; Peilong Li; Ning Wang; Mengjie Han; Lan Wang; Lu Wang Journal: Front Med (Lausanne) Date: 2022-05-24